Charles River Laboratories Total Liabilities and Share Holders Equity 2010-2024 | CRL

Charles River Laboratories total liabilities and share holders equity for the quarter ending September 30, 2024 was $8.004B, a 5.22% increase year-over-year.

  • Charles River Laboratories total liabilities and share holders equity for 2023 was $8.195B, a 7.79% increase from 2022.
  • Charles River Laboratories total liabilities and share holders equity for 2022 was $7.603B, a 8.24% increase from 2021.
  • Charles River Laboratories total liabilities and share holders equity for 2021 was $7.024B, a 27.93% increase from 2020.

Charles River Laboratories Total Liabilities and Share Holders Equity 2010-2024 | CRL

  • Charles River Laboratories total liabilities and share holders equity for 2023 was $8.195B, a 7.79% increase from 2022.
  • Charles River Laboratories total liabilities and share holders equity for 2022 was $7.603B, a 8.24% increase from 2021.
  • Charles River Laboratories total liabilities and share holders equity for 2021 was $7.024B, a 27.93% increase from 2020.